Top 5 Wellness VC (Venture Capital) Funds in Taiwan in February 2025

Last updated: Feb 2025 A list of 5 VC (Venture Capital) funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.

Top 5 Wellness VC (Venture Capital) Funds in Taiwan in February 2025

Investor	Wellness Taiwan investments
Suzhou Industrial Park Nankai Venture Capital	1
Panacea Venture	1
Guangzhou Yuexiu Industrial Investment Fund	1
Zero2IPO Ventures	1
Sino Biopharmaceutical	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.

Investment focus

Wellness, Health Care, Consumer Research
Series A
Taiwan

Portfolio highlights

HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.

Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Seed
China, United States, Taiwan

Portfolio highlights

Chime Biologics — Chime Biologics, is a world-class experienced Contract Development and Manufacturing Organization (CDMO), providing customer-centric and cost-effective services for timely premier-quality biopharmaceutical development and manufacturing. We provide a comprehensive solution supporting our customers from analytical and process transfer to early-stagebiopharmaceutical development through late-stage clinical and commercial drug substance and drug product manufacturing for Global Supply.
Base Therapeutics — Best Bio is a developer of cell therapy products and gene therapy products.
Eos BioInnovation — We are dedicated to incubating, launching, and building early-stage companies emerging from leading academic labs and research institutions in regenerative medicine.

Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.

Investment focus

Manufacturing, Health Care, Biotechnology
Series B, Series C, Series A
China, United States

Portfolio highlights

EurekaBio — EurekaBio is a leading upstream core vendor in the field of Cell and Gene Therapy (CGT), focusing on innovative research and development of cutting-edge technologies and key equipment essential for advancing CGT.
Sonosemi Medical — Sonosemi Medical is a provider of medical devices that specializes in the development of pan-vascular active interventional products, diagnosis, and treatment solutions.
Chunqing Technology — Chunqing Technology is a company that create new generation of electric vehicles powered by alcohol and hydrogen. Chunqing Technology creates, manufactures, and distributes alcohol and hydrogen energy for the next generation of electric automobiles.

Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.

Investment focus

E-Commerce, Internet, Education
Series A, Series B, Angel
China, India, Taiwan

Portfolio highlights

AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development

Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.